Overview

A Randomized, Double-Blind Trial Comparing the Efficacy and Safety of Fenofibrate, Metformin, Their Combination and Placebo in Patients With Metabolic Syndrome.

Status:
Completed

Trial end date:
2004-06-01

Target enrollment:

Participant gender:

Summary

The purpose of this study was to study the effect of different combinations of fenofibrate and metformin on the cluster of metabolic syndrome (MetS) biochemical abnormalities, and to determine the dose combination allowing normalization of MetS patients.

Phase:

Phase 2

Details

Lead Sponsor:

Solvay Pharmaceuticals

Treatments:

Fenofibrate
Metformin